1457-85-8,MFCD00009118
Catalog No.:AA001D92

1457-85-8 | Ethyl oxanilate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
2 weeks  
$70.00   $49.00
- +
2g
97%
2 weeks  
$84.00   $59.00
- +
5g
97%
2 weeks  
$110.00   $77.00
- +
25g
96%+;RG
2 weeks  
$479.00   $335.00
- +
100g
96%+;RG
2 weeks  
$1,627.00   $1,139.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001D92
Chemical Name:
Ethyl oxanilate
CAS Number:
1457-85-8
Molecular Formula:
C10H11NO3
Molecular Weight:
193.1992
MDL Number:
MFCD00009118
SMILES:
CCOC(=O)C(=O)Nc1ccccc1
NSC Number:
5606
Properties
Properties
 
BP:
280.0°C  
Form:
Solid  
MP:
67-69 °C(lit.)  
Refractive Index:
1.5300 (estimate)  
Storage:
Room Temperature;  

Computed Properties
 
Complexity:
209  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.5  

Downstream Synthesis Route
107-10-8    1457-85-8   
<i>N</i>-phenyl-<i>N</i>'-propyl-oxalamide 

[1]Richardsonetal.[JournaloftheAmericanChemicalSociety,1952,vol.74,p.4011]

[1]Schiff;Monsacchi[JustusLiebigsAnnalenderChemie,1895,vol.288,p.316]

[2]Hynes,J.B.etal.[JournalofMedicinalChemistry,1973,vol.16,p.576-578]

[3]Petyunin,G.P.etal.[PharmaceuticalChemistryJournal,1978,vol.12,p.780-782][Khimiko-FarmatsevticheskiiZhurnal,1978,vol.12,#6,p.106-108]

[1]Klinger[JustusLiebigsAnnalenderChemie,1877,vol.184,p.263]

[1]Dato,FlorianM.;Neudörfl,Jörg-Martin;Gütschow,Michael;Goldfuss,Bernd;Pietsch,Markus[BioorganicChemistry,2020,vol.94]

[2]Bycroft,BarrieW.;Gledhill,Linden;Shute,RichardE.;Williams,Paul[JournaloftheChemicalSociety.Chemicalcommunications,1988,#24,p.1610-1612]

[3]Ibrahim,YehiaA.;Al-Awadi,NouriaA.;Al-Azemi,TalalF.;John,Elizabeth[RSCAdvances,2014,vol.4,#73,p.38869-38876]

[4]Klinger[JustusLiebigsAnnalenderChemie,1877,vol.184,p.263]

[5]Locationinpatent:experimentalpartYamada,Yuko;Ochiai,Chihiro;Yoshimura,Kazuhisa;Tanaka,Tomohiro;Ohashi,Nami;Narumi,Tetsuo;Nomura,Wataru;Harada,Shigeyoshi;Matsushita,Shuzo;Tamamura,Hirokazu[BioorganicandMedicinalChemistryLetters,2010,vol.20,#1,p.354-358]

[6]Locationinpatent:experimentalpartZhao,Yu;Mao,Chunhui;Li,Yongqiang;Zhang,Pengxiang;Huang,Zhiqiang;Bi,Fuchun;Huang,Runqiu;Wang,Qingmin[JournalofAgriculturalandFoodChemistry,2008,vol.56,#16,p.7326-7332]

[7]Mou,Jianfeng;Wu,Songliang;Luo,Zhi;Guo,Fengying;He,Haiying;Wang,Jianhua;Lin,Fusen;Guo,Fengxun;Sun,Jianping;Shen,Liang;Zeng,Minggao;Wang,Chuan;Xu,Deming;Gu,Zhengxian;Tian,Xin;Zhang,Aiming;Xu,Hongjiang;Yang,Ling;Zhang,Xiquan;Li,Jian;Chen,Shuhui[BioorganicandMedicinalChemistryLetters,2018,vol.28,#10,p.1874-1878]

[8]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-EP3456711,2019,A1Locationinpatent:Paragraph0585;0587

[9]Westwood,MatthewT.;Lamb,ClaireJ.C.;Sutherland,DanielR.;Lee,Ai-Lan[OrganicLetters,2019,vol.21,#17,p.7119-7123]

[1]Sun,Bin;Liu,Kai;Han,Jing;Zhao,Li-Yu;Su,Xiao;Lin,Bin;Zhao,Dong-Mei;Cheng,Mao-Sheng[BioorganicandMedicinalChemistry,2015,vol.23,#20,p.6763-6773]

[2]CurrentPatentAssignee:SHENYANGPHARMACEUTICALUNIVERSITY-CN105541828,2016,ALocationinpatent:Paragraph0333;0334

[3]Reissert[ChemischeBerichte,1904,vol.37,p.3730]

[4]Reissert[ChemischeBerichte,1904,vol.37,p.3730]

[5]CurrentPatentAssignee:DICCORP.-JP2020/75873,2020,ALocationinpatent:Paragraph0320;0323

[6]Cheng,Maosheng;Su,Xin;Sun,Nannan;Sun,Yin;Tian,Linfeng;Yin,Wenbo;Zhang,Chu;Zhao,Dongmei;Zhao,Liyu;Zhao,Shizhen;Zheng,Yang[EuropeanJournalofMedicinalChemistry,2022,vol.228]

[7]Cheng,Maosheng;Su,Xin;Sun,Nannan;Sun,Yin;Tian,Linfeng;Yin,Wenbo;Zhang,Chu;Zhao,Dongmei;Zhao,Liyu;Zhao,Shizhen;Zheng,Yang[EuropeanJournalofMedicinalChemistry,2022,vol.228]

[8]Li,Jiarong;Meng,Zihui;Wang,Hongyi;Wang,Yiyun;Xu,Haojie;Xu,Zhibin;Xue,Min;Zheng,Zhonghui[ChemicalBiologyandDrugDesign,2022]

Literature

Title: Ethyl N-phenyloxamate.

Journal: Acta crystallographica. Section C, Crystal structure communications 20031001

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:1457-85-8 Molecular Formula|1457-85-8 MDL|1457-85-8 SMILES|1457-85-8 Ethyl oxanilate
Catalog No.: AA001D92
1457-85-8,MFCD00009118
1457-85-8 | Ethyl oxanilate
Pack Size: 1g
Purity: 97%
2 weeks
$70.00 $49.00
Pack Size: 2g
Purity: 97%
2 weeks
$84.00 $59.00
Pack Size: 5g
Purity: 97%
2 weeks
$110.00 $77.00
Pack Size: 25g
Purity: 96%+;RG
2 weeks
$479.00 $335.00
Pack Size: 100g
Purity: 96%+;RG
2 weeks
$1,627.00 $1,139.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001D92
Chemical Name: Ethyl oxanilate
CAS Number: 1457-85-8
Molecular Formula: C10H11NO3
Molecular Weight: 193.1992
MDL Number: MFCD00009118
SMILES: CCOC(=O)C(=O)Nc1ccccc1
NSC Number: 5606
Properties
BP: 280.0°C  
Form: Solid  
MP: 67-69 °C(lit.)  
Refractive Index: 1.5300 (estimate)  
Storage: Room Temperature;  
Complexity: 209  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.5  
Downstream Synthesis Route
107-10-8    1457-85-8   
<i>N</i>-phenyl-<i>N</i>'-propyl-oxalamide 

[1]Richardsonetal.[JournaloftheAmericanChemicalSociety,1952,vol.74,p.4011]

1457-85-8    42022-36-6 

[1]Schiff;Monsacchi[JustusLiebigsAnnalenderChemie,1895,vol.288,p.316]

[2]Hynes,J.B.etal.[JournalofMedicinalChemistry,1973,vol.16,p.576-578]

[3]Petyunin,G.P.etal.[PharmaceuticalChemistryJournal,1978,vol.12,p.780-782][Khimiko-FarmatsevticheskiiZhurnal,1978,vol.12,#6,p.106-108]

1457-85-8    24451-15-8 

[1]Klinger[JustusLiebigsAnnalenderChemie,1877,vol.184,p.263]

1457-85-8    500-72-1 

[1]Dato,FlorianM.;Neudörfl,Jörg-Martin;Gütschow,Michael;Goldfuss,Bernd;Pietsch,Markus[BioorganicChemistry,2020,vol.94]

[2]Bycroft,BarrieW.;Gledhill,Linden;Shute,RichardE.;Williams,Paul[JournaloftheChemicalSociety.Chemicalcommunications,1988,#24,p.1610-1612]

[3]Ibrahim,YehiaA.;Al-Awadi,NouriaA.;Al-Azemi,TalalF.;John,Elizabeth[RSCAdvances,2014,vol.4,#73,p.38869-38876]

[4]Klinger[JustusLiebigsAnnalenderChemie,1877,vol.184,p.263]

[5]Locationinpatent:experimentalpartYamada,Yuko;Ochiai,Chihiro;Yoshimura,Kazuhisa;Tanaka,Tomohiro;Ohashi,Nami;Narumi,Tetsuo;Nomura,Wataru;Harada,Shigeyoshi;Matsushita,Shuzo;Tamamura,Hirokazu[BioorganicandMedicinalChemistryLetters,2010,vol.20,#1,p.354-358]

[6]Locationinpatent:experimentalpartZhao,Yu;Mao,Chunhui;Li,Yongqiang;Zhang,Pengxiang;Huang,Zhiqiang;Bi,Fuchun;Huang,Runqiu;Wang,Qingmin[JournalofAgriculturalandFoodChemistry,2008,vol.56,#16,p.7326-7332]

[7]Mou,Jianfeng;Wu,Songliang;Luo,Zhi;Guo,Fengying;He,Haiying;Wang,Jianhua;Lin,Fusen;Guo,Fengxun;Sun,Jianping;Shen,Liang;Zeng,Minggao;Wang,Chuan;Xu,Deming;Gu,Zhengxian;Tian,Xin;Zhang,Aiming;Xu,Hongjiang;Yang,Ling;Zhang,Xiquan;Li,Jian;Chen,Shuhui[BioorganicandMedicinalChemistryLetters,2018,vol.28,#10,p.1874-1878]

[8]CurrentPatentAssignee:SINOBIOPHARMACEUTICALLIMITED-EP3456711,2019,A1Locationinpatent:Paragraph0585;0587

[9]Westwood,MatthewT.;Lamb,ClaireJ.C.;Sutherland,DanielR.;Lee,Ai-Lan[OrganicLetters,2019,vol.21,#17,p.7119-7123]

1457-85-8    56934-77-1 

[1]Sun,Bin;Liu,Kai;Han,Jing;Zhao,Li-Yu;Su,Xiao;Lin,Bin;Zhao,Dong-Mei;Cheng,Mao-Sheng[BioorganicandMedicinalChemistry,2015,vol.23,#20,p.6763-6773]

[2]CurrentPatentAssignee:SHENYANGPHARMACEUTICALUNIVERSITY-CN105541828,2016,ALocationinpatent:Paragraph0333;0334

[3]Reissert[ChemischeBerichte,1904,vol.37,p.3730]

[4]Reissert[ChemischeBerichte,1904,vol.37,p.3730]

[5]CurrentPatentAssignee:DICCORP.-JP2020/75873,2020,ALocationinpatent:Paragraph0320;0323

[6]Cheng,Maosheng;Su,Xin;Sun,Nannan;Sun,Yin;Tian,Linfeng;Yin,Wenbo;Zhang,Chu;Zhao,Dongmei;Zhao,Liyu;Zhao,Shizhen;Zheng,Yang[EuropeanJournalofMedicinalChemistry,2022,vol.228]

[7]Cheng,Maosheng;Su,Xin;Sun,Nannan;Sun,Yin;Tian,Linfeng;Yin,Wenbo;Zhang,Chu;Zhao,Dongmei;Zhao,Liyu;Zhao,Shizhen;Zheng,Yang[EuropeanJournalofMedicinalChemistry,2022,vol.228]

[8]Li,Jiarong;Meng,Zihui;Wang,Hongyi;Wang,Yiyun;Xu,Haojie;Xu,Zhibin;Xue,Min;Zheng,Zhonghui[ChemicalBiologyandDrugDesign,2022]

Literature fold

Title: Ethyl N-phenyloxamate.

Journal: Acta crystallographica. Section C, Crystal structure communications20031001

Building Blocks More >
146033-02-5
146033-02-5
Dibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-[1-oxo-3-(4-pyridinyl)propyl]hydrazide, hydrochloride (1:1)
AA001DJM | MFCD17215974
146307-51-9
146307-51-9
Methyl trans-4-(N-Boc-amino)cyclohexanecarboxylate
AA001DTG | MFCD17015041
146670-40-8
146670-40-8
Benzoic acid, 4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-
AA001E4V | MFCD00864137
14702-32-0
14702-32-0
2,5-Furandione, dihydro-3,3-diphenyl-
AA001EGA | MFCD30834505
14731-40-9
14731-40-9
Pyrrolidine, 1-(3-butyn-1-yl)-
AA001EPH | MFCD18841064
147676-56-0
147676-56-0
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[2-[4-(2-hydroxyethyl)-1-piperazinyl]acetyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-
AA001EZM | MFCD11046402
14799-66-7
14799-66-7
Silane, 1,1'-(1,6-hexanediyl)bis[1-chloro-1,1-dimethyl-
AA001FA1 | MFCD00054822
140924-50-1
140924-50-1
(Dhq)2phal
AA001FK6 | MFCD28014549
14126-37-5
14126-37-5
Bis(triphenylphosphine)nickel(II) bromide
AA001G34 | MFCD00015865
1416354-38-5
1416354-38-5
4-(2-Phenylpropan-2-yl)aniline hydrochloride
AA001GN9 | MFCD23135242
Submit
© 2017 AA BLOCKS, INC. All rights reserved.